Nebivolol (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nebivolol" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

5nih.gov

4^th place

8^th place

4doi.org

2^nd place

5^th place

3springer.com

274^th place

310^th place

3lww.com

2,769^th place

3,046^th place

2drugs.com

399^th place

169^th place

2clincalc.com

3,912^th place

low place

2ahajournals.org

3,608^th place

1,222^nd place

2archive.org

6^th place

9^th place

1cbz.si

low place

607^th place

1tandfonline.com

507^th place

185^th place

1semanticscholar.org

11^th place

51^st place

1sciencedirect.com

149^th place

140^th place

1frx.com

low place

1wiley.com

222^nd place

163^rd place

1zenodo.org

621^st place

911^th place

1ualberta.ca

3,600^th place

6,702^nd place

1atypon-link.com

low place

1elsevier.com

610^th place

311^th place

1dustri.com

low place

1oup.com

485^th place

503^rd place

1fda.gov

447^th place

409^th place

ahajournals.org

Reboussin, David M. (13. november 2017). »Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines«. AHA Journals. Pridobljeno 14. februarja 2022.
Galougahi, Keyvan Karimi (19. februar 2016). »β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia«. Journal of the American Heart Association. Pridobljeno 16. februarja 2022.

archive.org

Tafreshi MJ, Weinacker AB (Avgust 1999). »Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma«. Pharmacotherapy. 19 (8): 974–8. doi:10.1592/phco.19.11.974.31575. PMID 10453968. S2CID 32202416.
Rang HP, Dale MM, Ritter JM, Moore PK (2003). Pharmacology (5th izd.). Edinburgh: Churchill Livingstone. str. 163. ISBN 0-443-07145-4.

atypon-link.com

Weiss, R. »Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation«. Atypon. Pridobljeno 16. februarja 2022.

cbz.si

»Centralna baza zdravil«. Pridobljeno 12. februarja 2022.

clincalc.com

»The Top 300 of 2019«. Clin Calc. Pridobljeno 13. februarja 2022.
»Nebivolol«. Clin Calc. Pridobljeno 13. februarja 2022.

doi.org

Tafreshi MJ, Weinacker AB (Avgust 1999). »Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma«. Pharmacotherapy. 19 (8): 974–8. doi:10.1592/phco.19.11.974.31575. PMID 10453968. S2CID 32202416.
Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C (april 2009). »Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart«. Journal of the American College of Cardiology. 53 (17): 1532–1538. doi:10.1016/j.jacc.2008.11.057. PMID 19389564.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Sawa M, Harada H (2006). »Recent developments in the design of orally bioavailable beta3-adrenergic receptor agonists«. Current Medicinal Chemistry. 13 (1): 25–37. doi:10.2174/092986706775198006. PMID 16457637.
Ferrer-Lorente R, Cabot C, Fernández-López JA, Alemany M (september 2005). »Combined effects of oleoyl-estrone and a beta3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats«. Life Sciences. 77 (16): 2051–8. doi:10.1016/j.lfs.2005.04.008. PMID 15935402.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

drugs.com

»Nebivolol Hydrochloride«. Drugs. Pridobljeno 10. februarja 2022.
»Nebivolol Pregnancy and Breastfeeding Warnings«. Drugs. Pridobljeno 10. februarja 2022.

dustri.com

Gielen, W. »Nebivolol: a review of its clinical and pharmacological characteristics«. Dustri-Verlag. Pridobljeno 16. februarja 2022.

elsevier.com

linkinghub.elsevier.com

Kamp, Otto (1. avgust 2003). »Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension«. The American Journal of Cardiology. Pridobljeno 16. februarja 2022.

fda.gov

»Warning Letter« (PDF). FDA. Pridobljeno 16. februarja 2022.

frx.com

»Prescribing information for Bystolic« (PDF). Pridobljeno 15. februarja 2022.

lww.com

journals.lww.com

Bakris, George. »An In-depth Analysis of Vasodilation in the Management of Hypertension: Focus on Adrenergic Blockade«. Journal of Cardiovascular Pharmacology. Pridobljeno 16. februarja 2022.
Pessina, Achille C. »Metabolic Effects and Safety Profile of Nebivolol«. Journal of Cardiovascular Pharmacology. Pridobljeno 16. februarja 2022.
Poirier, Luc. »Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients«. Journal of Hypertension. Pridobljeno 16. februarja 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Tafreshi MJ, Weinacker AB (Avgust 1999). »Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma«. Pharmacotherapy. 19 (8): 974–8. doi:10.1592/phco.19.11.974.31575. PMID 10453968. S2CID 32202416.
Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C (april 2009). »Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart«. Journal of the American College of Cardiology. 53 (17): 1532–1538. doi:10.1016/j.jacc.2008.11.057. PMID 19389564.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Sawa M, Harada H (2006). »Recent developments in the design of orally bioavailable beta3-adrenergic receptor agonists«. Current Medicinal Chemistry. 13 (1): 25–37. doi:10.2174/092986706775198006. PMID 16457637.
Ferrer-Lorente R, Cabot C, Fernández-López JA, Alemany M (september 2005). »Combined effects of oleoyl-estrone and a beta3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats«. Life Sciences. 77 (16): 2051–8. doi:10.1016/j.lfs.2005.04.008. PMID 15935402.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

ncbi.nlm.nih.gov

Fretheim, Atle (5. april 2012). »Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis«. NCBI. Pridobljeno 14. februarja 2022.

oup.com

academic.oup.com

Weber, Michael A. (1. december 2005). »The Role of the New β-Blockers in Treating Cardiovascular Disease«. American Journal of Hypertension. Pridobljeno 16. februarja 2022.

sciencedirect.com

Bundkirchen, Andreas (26. januar 2003). »β1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies«. Science Direct. Pridobljeno 15. februarja 2022.

semanticscholar.org

api.semanticscholar.org

Tafreshi MJ, Weinacker AB (Avgust 1999). »Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma«. Pharmacotherapy. 19 (8): 974–8. doi:10.1592/phco.19.11.974.31575. PMID 10453968. S2CID 32202416.

springer.com

link.springer.com

Bocchino Seleme, Vinicius (25. julij 2020). »Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis«. Springer Link. Pridobljeno 14. februarja 2022.
Rosei, Enrico Agabiti; Rizzoni, Damiano (18. september 2012). »Metabolic Profile of Nebivolol, a β-Adrenoceptor Antagonist with Unique Characteristics«. Springer Link. Pridobljeno 16. februarja 2022.
Baldwin, Claudine M.; Keam, Susan J. (17. avgust 2012). »Nebivolol«. Springer Link. Pridobljeno 16. februarja 2022.

tandfonline.com

de Boer, Rudolf A.; Voors, Adriaan A.; van Veldhuisen, Dirk J. (30. julij 2007). »Nebivolol: third-generation β-blockade«. Taylor & Francis Online. Pridobljeno 13. februarja 2022.

ualberta.ca

journals.library.ualberta.ca

Gheldiu, Ana-Maria; Vlase, Laurian. »Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy Volunteers«. Journal of Pharmacy & Pharmaceutical Sciences. Pridobljeno 15. februarja 2022.

wiley.com

onlinelibrary.wiley.com

Nuttall, S. L. (10. junij 2003). »A comparison of the β1-selectivity of three β1-selective β-blockers«. Wiley Online Library. Pridobljeno 15. februarja 2022.

zenodo.org

Ferrer-Lorente R, Cabot C, Fernández-López JA, Alemany M (september 2005). »Combined effects of oleoyl-estrone and a beta3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats«. Life Sciences. 77 (16): 2051–8. doi:10.1016/j.lfs.2005.04.008. PMID 15935402.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)